These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3913528)

  • 41. Application of drug-containing liposomes to the duration of the intramuscular absorption of water-soluble drugs in rats.
    Arakawa E; Imai Y; Kobayashi H; Okumura K; Sezaki H
    Chem Pharm Bull (Tokyo); 1975 Oct; 23(10):2218-22. PubMed ID: 1212751
    [No Abstract]   [Full Text] [Related]  

  • 42. Bioadhesive polymers for oral drug delivery.
    Ríhová B; Rathi RC; Kopecková P; Kopecek J
    Adv Exp Med Biol; 1995; 371B():1491-4. PubMed ID: 7502843
    [No Abstract]   [Full Text] [Related]  

  • 43. Use of monoclonal antibodies and liposomes to improve drug delivery. Present status and future implications.
    Gregoriadis G
    Drugs; 1982 Oct; 24(4):261-6. PubMed ID: 7140578
    [No Abstract]   [Full Text] [Related]  

  • 44. Liposomes in vivo: prospects for liposome-based pharmaceuticals in the 1990s.
    Senior JH
    Biotechnol Genet Eng Rev; 1990; 8():279-317. PubMed ID: 2094273
    [No Abstract]   [Full Text] [Related]  

  • 45. Targeting of drugs.
    Gregoriadis G
    Nature; 1977 Feb; 265(5593):407-11. PubMed ID: 834290
    [No Abstract]   [Full Text] [Related]  

  • 46. Recent Advances in Oral Peptide or Protein-Based Drug Liposomes.
    Cui J; Wen Z; Zhang W; Wu W
    Pharmaceuticals (Basel); 2022 Aug; 15(9):. PubMed ID: 36145293
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting of drugs: implications in medicine.
    Gregoriadis G
    Lancet; 1981 Aug; 2(8240):241-6. PubMed ID: 6114292
    [No Abstract]   [Full Text] [Related]  

  • 48. Oral ingestion of insulin liposomes: effects of the administration route.
    Weingarten C; Moufti A; Desjeux JF; Luong TT; Durand G; Devissaguet JP; Puisieux F
    Life Sci; 1981 Jun; 28(24):2747-52. PubMed ID: 7022080
    [No Abstract]   [Full Text] [Related]  

  • 49. Old drugs in new clothing.
    Gregoriadis G
    Nature; 1984 Jul 19-25; 310(5974):186-7. PubMed ID: 6462205
    [No Abstract]   [Full Text] [Related]  

  • 50. Application of liposome-entrapped drugs.
    Kumashiro H; Mori N; Fukatsu T; Sato T
    Jpn J Psychiatry Neurol; 1986 Sep; 40(3):367-8. PubMed ID: 3106690
    [No Abstract]   [Full Text] [Related]  

  • 51. Liposomes as a controlled-release system.
    Patel HM
    Biochem Soc Trans; 1985 Apr; 13(2):513-6. PubMed ID: 3894112
    [No Abstract]   [Full Text] [Related]  

  • 52. Oral administration of liposomally-entrapped heparin to beagle dogs.
    Ueno M; Nakasaki T; Horikoshi I; Sakuragawa N
    Chem Pharm Bull (Tokyo); 1982 Jun; 30(6):2245-7. PubMed ID: 7127610
    [No Abstract]   [Full Text] [Related]  

  • 53. [Drug information. Statement of measurement specially for many small amounts].
    Dahlerup J
    Sygeplejersken; 1986 Jan; 86(2):17. PubMed ID: 3642800
    [No Abstract]   [Full Text] [Related]  

  • 54. The use of liposomes as enzyme carriers. I. Dependence of enzyme stability on the method of preparation.
    Kurosaki Y; Kimura T; Muranishi S; Sezaki H
    Chem Pharm Bull (Tokyo); 1981 Apr; 29(4):1175-8. PubMed ID: 7273259
    [No Abstract]   [Full Text] [Related]  

  • 55. Further studies in the mouse intra-oral inoculation technique.
    EPSTEIN SS; STRATTON K
    J Hyg (Lond); 1958 Mar; 56(1):80-3. PubMed ID: 13525718
    [No Abstract]   [Full Text] [Related]  

  • 56. The potential of liposomes in oral drug delivery.
    Rogers JA; Anderson KE
    Crit Rev Ther Drug Carrier Syst; 1998; 15(5):421-80. PubMed ID: 9822867
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exploring LIPIDs for their potential to improves bioavailability of lipophilic drugs candidates: A review.
    Preeti ; Sambhakar S; Saharan R; Narwal S; Malik R; Gahlot V; Khalid A; Najmi A; Zoghebi K; Halawi MA; Albratty M; Mohan S
    Saudi Pharm J; 2023 Dec; 31(12):101870. PubMed ID: 38053738
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Natural Polysaccharide-Based Nanodrug Delivery Systems for Treatment of Diabetes.
    Qiu A; Wang Y; Zhang G; Wang H
    Polymers (Basel); 2022 Aug; 14(15):. PubMed ID: 35956731
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liposomal-encapsulated Ascorbic Acid: Influence on Vitamin C Bioavailability and Capacity to Protect Against Ischemia-Reperfusion Injury.
    Davis JL; Paris HL; Beals JW; Binns SE; Giordano GR; Scalzo RL; Schweder MM; Blair E; Bell C
    Nutr Metab Insights; 2016; 9():25-30. PubMed ID: 27375360
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimization on condition of epigallocatechin-3-gallate (EGCG) nanoliposomes by response surface methodology and cellular uptake studies in Caco-2 cells.
    Luo X; Guan R; Chen X; Tao M; Ma J; Zhao J
    Nanoscale Res Lett; 2014; 9(1):291. PubMed ID: 24959109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.